Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

BACKGROUND: Stimulant medications for the treatment of attention-deficit/hyperactivity disorder have a history of safe and effective use; however, concerns exist that they may adversely affect growth trajectories in children and adolescents. OBJECTIVE: The objective of this study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Banaschewski, Tobias, Johnson, Mats, Nagy, Peter, Otero, Isabel Hernández, Soutullo, César A., Yan, Brian, Zuddas, Alessandro, Coghill, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976689/
https://www.ncbi.nlm.nih.gov/pubmed/29790103
http://dx.doi.org/10.1007/s40263-018-0514-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976689/
https://www.ncbi.nlm.nih.gov/pubmed/29790103
http://dx.doi.org/10.1007/s40263-018-0514-8

Ejemplares similares